The activity of HIF-1α, rather antitumorigenic in this specific cancer, is strongly decreased due to chromosomal deletions [38] or HAF activity [39] leaving HIF-2 to fully exert its pro-tumor activity. The gene discussed is HIF1A; the disease is neoplasm.